Strategikon Pharma
Clinical Study Planning - Clinical Trial Business Operations | Clinical Maestro®
San Francisco, United States · Founded 2017 · $7.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- SaaS
- Website
- strategikon.com
- Total Funding
- $7.0M
- Last Round
- $7.0M Series AFeb 2024
- Rounds
- 2
About
Develops Clinical Maestro, AI-powered software suite that reduces clinical trial costs by 80% or more.
Summary
Strategikon Pharma is a Biotech company based in San Francisco, United States, founded in 2017. It has raised $7.0M in total across 2 rounds, most recently a $7.0M Series A round in Feb 2024. Investors include Osage Venture Partners, Debiopharm Innovation and Hearstlab.
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...